Evo Fund lowers stake in SymBio Pharmaceuticals to 32.80%
Stake history
Summary
Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2025-10-29 13:46 JST concerning SymBio Pharmaceuticals Limited. Reported holding ratio: 32.80%, previous report: 33.20%.